3,418
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Rabdosia rubescens Linn: green synthesis of gold nanoparticles and their anticancer effects against human lung cancer cells A549

, , , &
Pages 2171-2178 | Received 22 Dec 2018, Accepted 10 May 2019, Published online: 04 Jun 2019

References

  • Suganthy N, Sri Ramkumar V, Pugazhendhi A, et al. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ Sci Pollut Res Int. 2018;25:10418–10433.
  • Schluesener JK, Schluesener HJ. Nanosilver: application and novel aspects of toxicology. Arch Toxicol. 2013;87:569–576.
  • Poulose S, Panda T, Nair PP, et al. Biosynthesis of silver nanoparticles. J Nanosci Nanotechnol. 2014;14:2038–2049.
  • Chandran SP, Chaudhary M, Pasricha R, et al. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 2006;22:577–583.
  • Sadhasivam S, Shanmugam P, Yun K. Biosynthesis of silver nanoparticles by Streptomyces hygroscopicus and antimicrobial activity against medically important pathogenic microorganisms. Colloids Surf B Biointerf. 2010;1;81:358–362.
  • Leng C, Wu J, Xu Q, et al. A highly sensitive disposable immunosensor through direct electro-reduction of oxygen catalyzed by palladium nanoparticle decorated carbon nanotube label. Biosens Bioelectron. 2011;27:71–76.
  • Jain SK, Gupta Y, Jain A, et al. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine. 2008;4:41–48.
  • Aswathy J, Jahnavi S, Krishna R, et al. Targeted labeling of cancer cells using biotin tagged avidin functionalized biocompatible fluorescent nanocrystals. J Nanosci Nanotech. 2011;11:7611–7620.
  • Philip D. Mangifera indica leaf-assisted biosynthesis of well-dispersed silver nanoparticles. Spectrochim Acta A Mol Biomol Spectrosc. 2011;78:327–331.
  • Di Paola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med. 1998;339:785–791.
  • Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27–31.
  • National Pharmacopoeia Committee. Pharmacopoeia of People's Republic of China 2015. Beijing, China: National Pharmacopoeia Committee; 2015.
  • Zhao J, Deng JW, Chen YW, et al. Advanced phytochemical analysis of herbal tea in China. J Chromatogr A. 2013;1313:2
  • Takeda Y, Otsuka H. Recent advances in the chemistry of diterpenoids from Rabdosia species. Stud Nat Prod Chem. 1995;15:111e85.
  • Liu C, Zhao Z. Advances in research of Rabdosia rubescens (Hemsl.) Hara. Chin Pharm J. 1998;33:577e81.
  • Sun HD, Lin ZW, Qin CQ, et al. Studies on the chemical constituents of antitumor plant Rabdosia rubescens (Hemsl.) Hara. Acta Bot Yunn. 1981;3:95e100.
  • National Cancer Institute. SEER Cancer Statistics Review, 1975–2011. Available online: http://seer.cancer.gov/csr/1975_2011/
  • National Cancer Center; 2017. National Cancer Registry Programme. Three Year Report of Population Based Cancer Registries: 2014–2017.
  • Curran WJ, Jr, Paulus R, Langer CJ, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103:1452–1460.
  • Li X, Kabolizadeh P, Yan D, et al. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy. Radiat Oncol. 2018;13:35.
  • Sinha R, Kim GJ, Nie S, et al. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006;5:1909–1917.
  • Sindhu K, Rajaram A, Sreeram KJ, et al. Curcumin conjugated gold nanoparticle synthesis and its biocompatibility. Rsc Advances. 2014;4:1–18.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
  • Klastersky J, Sculier JP, Bureau G, et al. Cisplatin versus cisplatin plus etoposide in treatment of advanced non-small cell lung cancer. Lung cancer working party, Belgium. JCO 1989;7:1087–1092.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
  • Govindaraju K, Basha SK, Kumar VG, et al. Silver, gold and bimetallic nanoparticles production using single-cell protein (Spirulina platensis) Geitler. J Mater Sci. 2008;43:5115–5122.
  • Fayaz MA, Tiwary CS, Kalaichelvan PT, et al. Blue orange light emission from biogenic synthesized silver nanoparticles using Trichoderma viride. Colloid Surf B Biointerf. 2010;75:175–178.
  • Ali DM, Sasikala M, Gunasekaran M, et al. Biosynthesis and characterization of silver nanoparticles using marine Cyanobacterium, Oscillatoria willei NTDM01. Digest J Nanomater Biostruct. 2011;6:385–390.
  • Sato K, Mochizuki M, Saiki I, et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 1994;17:635–639.
  • Blagoi YP, Galkin VL, Gladchenko GO, et al. Metal complexes of nucleic acids in solutions. Naukova Dymka, Kiev (in Russian). 1991. p. 272.
  • Martins D, Frungillo L, Anazzetti MC, et al. Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein. Int J Nanomed. 2010;5:77–85.
  • Kroemer G, El-Deiry WS, Golstein P, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2005;12:1463–1467.
  • Vaux D, Silke J. Mammalian mitochondrial IAP-binding proteins. Biochem Biophy Res Commun. 2003;203:449–504.
  • Kumar V, Abbas AK, Fausto N, et al. Robins and Cotran: pathologic basis of disease. 8th ed. Philadelphia: Saunders Elsevier; 2010, p. 25–32
  • O’Brien MA, Kirby R. Apoptosis: a review of pro-apoptotic and antiapoptotic pathways and dysregulation in disease. J Vet Emerg Crit Care. 2008; 18:572–585.
  • Karp G. Cell and molecular biology: concepts and experiments. 5th ed. New Jersey: John Wiley and Sons; 2008, p. 653–657.
  • Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in haematologic malignancies. Semin Haematol. 1997;34:9–19.
  • Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571